Kakyung Kim

Archives
Log in
Subscribe
November 7, 2026

๐Ÿ“ˆ econ-radar 2026-11-07 ยท AHA 2026 Late-Breaking Day 1: ์‹ฌํ˜ˆ๊ด€ R&D ๊ฒฐ๊ณผ ๋ฆด๋ ˆ์ด ์‹œ์ž‘

๐Ÿ“ˆ econ-radar 2026-11-07 ยท AHA 2026 Late-Breaking Day 1: ์‹ฌํ˜ˆ๊ด€ R&D ๊ฒฐ๊ณผ ๋ฆด๋ ˆ์ด ์‹œ์ž‘

๐Ÿ“ˆ econ-radar ๋ฐ์ผ๋ฆฌ

2026-11-07

์ œ์•ฝยท๋ฐ”์ด์˜คยทAI์— ๋ฌด๊ฒŒ๋ฅผ ๋‘” ๊ฒฝ์ œ ๋ฐ์ผ๋ฆฌ โ€” ์‚ฐ์—…๊ตฌ์กฐยทํˆฌ์žยท์‹œ์žฅ 3๋ Œ์ฆˆ

At a Glance

๐Ÿ’ฐ 10์›” ๋ฏธ๊ตญ ๊ณ ์šฉ์ด ์ปจ์„ผ์„œ์Šค์˜ 2.8๋ฐฐ์ธ +165,000๋ช…์œผ๋กœ ๋ฐœํ‘œ๋˜๋ฉด์„œ ์—ฐ์ค€์˜ 12์›” ๊ธˆ๋ฆฌ ์ธ์ƒ ๊ฒฝ๋กœ๊ฐ€ ์‚ฌ์‹ค์ƒ ๊ตณํ˜€์กŒ๋‹ค. AI ๋ฐ์ดํ„ฐ์„ผํ„ฐ ํˆฌ์ž์˜ ์ฑ„๊ถŒ ์กฐ๋‹ฌ ๋น„์šฉ๋„ ๊ทธ๋งŒํผ ๋” ์˜ค๋ฅธ๋‹ค.

๐Ÿค– OpenAI๊ฐ€ $110์–ต(์•ฝ 15์กฐ 2,000์–ต ์›) ์ถ”๊ฐ€ ์กฐ๋‹ฌ๋กœ ๋ฐธ๋ฅ˜์—์ด์…˜์„ $1.25์กฐ(์•ฝ 1,725์กฐ ์›)๋กœ ๋†’์ด๋Š” ์‚ฌ์ด, ๊ฒฝ์Ÿ์‚ฌ Anthropic์€ IPO ๋ชฉํ‘œ๊ฐ€๊ฐ€ $1.5์กฐ(์•ฝ 2,070์กฐ ์›)๋ฅผ ํ•˜ํšŒํ•  ์ˆ˜ ์žˆ๋‹ค๋Š” ํˆฌ์ž์ž ๊ฒฝ๊ณ ์— ์ง๋ฉดํ–ˆ๋‹ค. ๊ฐ™์€ AI 1์„ธ๋Œ€ ๊ฐ„์—๋„ ์ž๊ธˆ๋ ฅ ๊ฒฉ์ฐจ๊ฐ€ ๋ฒŒ์–ด์กŒ๋‹ค.

๐Ÿงฌ J&J ๋ฆฌ๋ธŒ๋ ˆ๋ฐ˜ํŠธ(amivantamab)๊ฐ€ ๋‘๊ฒฝ๋ถ€์•” FDA ๊ฐ€์†์Šน์ธ์„ ๋ฐ›์•„ 10๋…„ ๋งŒ์˜ ์‹ ๊ทœ ์น˜๋ฃŒ ์˜ต์…˜์ด ์ƒ๊ฒผ๋‹ค. ๊ฐ™์€ ๋‚  Novartis๋Š” ์กธ์  ์Šค๋งˆ ํˆฌ์—ฌ ํ™˜์ž 9๋ช…์—์„œ ์ข…์–‘์ด ๋ฐœ์ƒํ–ˆ๋‹ค๊ณ  ๊ณต๊ฐœํ•ด ์œ ์ „์ž์น˜๋ฃŒ ๋ถ„์•ผ ์•ˆ์ „์„ฑ ๋…ผ์Ÿ์„ ๋‹ค์‹œ ๋ถˆ๋ถ™์˜€๋‹ค.

Today's Top 5

Macro

1. ๋ฏธ 10์›” NFP +165,000๋ช… โ€” ์ปจ์„ผ์„œ์Šค ๋Œ€๋น„ 2.8๋ฐฐ ์„œํ”„๋ผ์ด์ฆˆ, ์—ฐ์ค€ 12์›” ์ถ”๊ฐ€ ์ธ์ƒ ๊ฒฝ๋กœ ํ™•์ •

10์›” ๋ฏธ๊ตญ ๋น„๋†์—… ๊ณ ์šฉ์ง€์ˆ˜(NFP)๊ฐ€ 165,000๋ช… ์ฆ๊ฐ€๋กœ ๋ฐœํ‘œ๋๋‹ค. ์‹œ์žฅ ์ปจ์„ผ์„œ์Šค(+59,000๋ช…)๋ฅผ ์•ฝ 2.8๋ฐฐ ์›ƒ๋Œ์•˜๊ณ , ์‹ค์—…๋ฅ ์€ 4.2%์—์„œ 4.1%๋กœ ํ•˜๋ฝํ–ˆ๋‹ค. FT๋Š” "๊ณ ์šฉ ๋ฐ˜๋“ฑ์ด ์—ฐ์ค€์˜ ์ถ”๊ฐ€ ๊ธˆ๋ฆฌ ์ธ์ƒ ๊ธฐ๋Œ€๋ฅผ ๊ฐ•ํ™”ํ•œ๋‹ค"๊ณ  ๋ณด๋„ํ–ˆ๋‹ค.

โ†— FT โ€” US economy adds 165,000 jobs

Bio

2. J&J ๋ฆฌ๋ธŒ๋ ˆ๋ฐ˜ํŠธ(amivantamab, Rybrevant) ๋‘๊ฒฝ๋ถ€์•” FDA ๊ฐ€์†์Šน์ธ โ€” 10๋…„ ๋งŒ์˜ ์‹ ๊ทœ ์˜ต์…˜

FDA๊ฐ€ J&J์˜ ํ•ญ์•”์ œ ๋ฆฌ๋ธŒ๋ ˆ๋ฐ˜ํŠธ(amivantamab)์— ํ™”ํ•™์š”๋ฒ• ๋ฐ ๋ฉด์—ญํ•ญ์•”์ œ ์น˜๋ฃŒ ํ›„ ์žฌ๋ฐœํ•œ ๋‘๊ฒฝ๋ถ€์•” ์ ์‘์ฆ์— ๋Œ€ํ•ด ๊ฐ€์†์Šน์ธ์„ ๋ถ€์—ฌํ–ˆ๋‹ค. Endpoints News๋Š” "๋‘๊ฒฝ๋ถ€์•” ๋ถ„์•ผ์—์„œ 10๋…„ ๋งŒ์˜ ์‹ ๊ทœ ์น˜๋ฃŒ ์˜ต์…˜"์ด๋ผ๊ณ  ๋ณด๋„ํ–ˆ๋‹ค. ๊ธฐ์กด NSCLC(๋น„์†Œ์„ธํฌํ์•”) ํ—ˆ๊ฐ€์— ์ด์–ด ๊ณ ํ˜•์•” ์ ์‘์ฆ์„ ํ™•์žฅํ–ˆ๋‹ค.

โ†— Endpoints โ€” J&J Rybrevant FDA approval head and neck

Bio

3. Novartis ์กธ์  ์Šค๋งˆ ์•” ๋ฐœ์ƒ 9๋ก€ ๊ณต๊ฐœ โ€” AAV ์‚ฝ์ž…๋ณ€์ด 2๊ฑด, ์œ ์ „์ž์น˜๋ฃŒ ์•ˆ์ „์„ฑ ๋…ผ์Ÿ ์žฌ์ ํ™”

Novartis๊ฐ€ ์ฒ™์ˆ˜์„ฑ ๊ทผ์œ„์ถ•์ฆ(SMA) ์œ ์ „์ž์น˜๋ฃŒ์ œ ์กธ์  ์Šค๋งˆ(Zolgensma) ํˆฌ์—ฌ ํ™˜์ž 9๋ช…์—์„œ ์ข…์–‘์ด ๋ฐœ์ƒํ–ˆ๋‹ค๊ณ  ๊ณต๊ฐœํ–ˆ๋‹ค. BioPharma Dive์— ๋”ฐ๋ฅด๋ฉด ์ด ์ค‘ 2๊ฑด์€ ๋ฐ”์ด๋Ÿด ์ „๋‹ฌ์ฒด(AAV ๋ฒกํ„ฐ)๊ฐ€ ํ™˜์ž DNA์— ์‚ฝ์ž…(insertional mutagenesis)๋œ ์ฆ๊ฑฐ๊ฐ€ ํ™•์ธ๋๋‹ค.

โ†— BioPharma Dive โ€” Zolgensma tumor report

AI

4. OpenAI $1.25์กฐ ๋‹ฌ๋Ÿฌ ์ถ”๊ฐ€ ์กฐ๋‹ฌ vs Anthropic IPO $1.5์กฐ ํ•˜ํšŒ ๊ฒฝ๊ณ  โ€” AI 1์„ธ๋Œ€์˜ ๊ฐˆ๋ฆผ๊ธธ

Bloomberg ๋ณด๋„์— ๋”ฐ๋ฅด๋ฉด OpenAI๊ฐ€ ์•„์ง ์ข…๊ฒฐ๋˜์ง€ ์•Š์€ ์‹ ๊ทœ ๋ผ์šด๋“œ์—์„œ $110์–ต(์•ฝ 15์กฐ 2,000์–ต ์›)์„ ์กฐ๋‹ฌํ•ด ๋ฐธ๋ฅ˜์—์ด์…˜์ด $1.25์กฐ(์•ฝ 1,725์กฐ ์›)๊ฐ€ ๋๋‹ค. ์˜ฌํ•ด 3์›” $852์–ต(์•ฝ 117์กฐ 6,000์–ต ์›) ๋ฐธ๋ฅ˜์—์ด์…˜์œผ๋กœ $1,220์–ต(์•ฝ 168์กฐ ์›)์„ ์กฐ๋‹ฌํ•œ ์ง€ ๋ถˆ๊ณผ ์ˆ˜๊ฐœ์›” ๋งŒ์ด๋‹ค. ๊ฐ™์€ ๋‚  CNBC๋Š” "AI ํˆฌ์ž ์‹ฌ๋ฆฌ ์•…ํ™”๋กœ Anthropic IPO ๋ชฉํ‘œ ๋ฐธ๋ฅ˜์—์ด์…˜์ด $1.5์กฐ๋ฅผ ํ•˜ํšŒํ•  ์ˆ˜ ์žˆ๋‹ค"๋Š” ํˆฌ์ž์ž ๊ฒฝ๊ณ ๋ฅผ ๋ณด๋„ํ–ˆ๋‹ค.

โ†— The Verge โ€” OpenAI $1.25T valuation

Bio

5. K๋ฐ”์ด์˜ค 5์‚ฌ 3Q ๋ชจ๋‘ YoY ์„ฑ์žฅ โ€” ์‚ผ์„ฑ๋ฐ”์ด์˜ค๋กœ์ง์Šค 1์กฐ 4,903์–ต ์›, ๊ทธ๋Ÿฌ๋‚˜ ์ •๋ถ€ ์‹ ์•ฝ R&D ํˆฌ์ž๋Š” 2๋…„ ์—ฐ์† ๊ฐ์†Œ

์‚ผ์„ฑ๋ฐ”์ด์˜ค๋กœ์ง์Šค, ์…€ํŠธ๋ฆฌ์˜จ, ์‚ผ์„ฑ๋ฐ”์ด์˜ค์—ํ”ผ์Šค, SK๋ฐ”์ด์˜คํŒœ, ์•Œํ…Œ์˜ค์   ๋“ฑ ๊ตญ๋‚ด ์ฃผ์š” ๋ฐ”์ด์˜ค 5์‚ฌ๊ฐ€ 2026๋…„ 3๋ถ„๊ธฐ ๋ชจ๋‘ ์ „๋…„ ๋™๊ธฐ ๋Œ€๋น„ ๋งค์ถœ๊ณผ ์˜์—…์ด์ต์„ ๋Š˜๋ ธ๋‹ค. ์‚ผ์„ฑ๋ฐ”์ด์˜ค๋กœ์ง์Šค๋Š” ๋งค์ถœ 1์กฐ 4,903์–ต ์›(+18.5% YoY), ์˜์—…์ด์ต 6,401์–ต ์›์ด์—ˆ๊ณ , 5๊ฐœ์‚ฌ ์˜์—…์ด์ต๋ฅ ์€ ์ตœ์ € 30.0%์—์„œ ์ตœ๊ณ  65.9%์˜€๋‹ค. ๋ฐ˜๋ฉด ๊ฐ™์€ ๋‚  ์—ฐํ•ฉ๋‰ด์Šค๋Š” 2024๋…„ ์ •๋ถ€ ์‹ ์•ฝ R&D ํˆฌ์ž๊ฐ€ 5,433์–ต ์›์œผ๋กœ 2022๋…„ ๊ณ ์ (6,219์–ต ์›) ๋Œ€๋น„ 2๋…„ ์—ฐ์† ๊ฐ์†Œํ–ˆ๋‹ค๊ณ  ๋ณด๋„ํ–ˆ๋‹ค.

โ†— ํžˆํŠธ๋‰ด์Šค โ€” K๋ฐ”์ด์˜ค 5์‚ฌ 3Q ์„ฑ์ ํ‘œ

๐Ÿ—ฃ ์˜ค๋Š˜์˜ ํ™”์ œ

์˜ค๋Š˜ Lp(a)HORIZON ํ•˜์œ„๊ตฐ ๋ฐ์ดํ„ฐ๊ฐ€ ๋‚˜์˜ค๋ฉด Lp(a) ํƒ€๊นƒ ์น˜๋ฃŒ ๊ฐœ๋ฐœ์˜ ๋ฐฉํ–ฅ์ด ๊ณ ์œ„ํ—˜๊ตฐ ์„ ๋ณ„๋กœ ์ขํ˜€์งˆ์ง€, ์•„๋‹ˆ๋ฉด ๊ฐ€์„ค ์ž์ฒด๊ฐ€ ํ”๋“ค๋ฆด์ง€ ํŒ๊ฐ€๋ฆ„๋‚œ๋‹ค.

์ „์ฒด ๋ฆฌํฌํŠธ ๋ณด๊ธฐ โ†’

Deep Dive ยท Demand ยท Investment ยท Companies ยท Sources ์ „์ฒด๋Š” ์œ„ ๋งํฌ์—์„œ ๋ณด์‹ค ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ…”๋ ˆ๊ทธ๋žจ @econradar ๋กœ๋„ ๋ฐ›๊ธฐ

econ-radar ยท 2026-11-07

ํˆฌ์ž ์ฐธ๊ณ ์šฉ ์ •๋ณด์ž…๋‹ˆ๋‹ค. ์ตœ์ข… ํŒ๋‹จ๊ณผ ์ฑ…์ž„์€ ๋ณธ์ธ์—๊ฒŒ ์žˆ์Šต๋‹ˆ๋‹ค.

Don't miss what's next. Subscribe to Kakyung Kim:
โ† Newer [์ฃผ๊ฐ„] econ-radar 2026๋…„ 45์ฃผ ๋™ํ–ฅ (11/2~11/8) Older โ†’ ๐Ÿ“ˆ econ-radar 2026-11-06 ยท KOSPI ์„œํ‚ท๋ธŒ๋ ˆ์ด์ปค: AI ๋ฐ˜๋„์ฒด ํˆฌ๋งค์˜ ๊ตฌ์กฐ์™€ ๋ฐ˜์ „ ์กฐ๊ฑด(KOSPI Circuit Breaker)
Powered by Buttondown, the easiest way to start and grow your newsletter.